Biomedical materials to meet the challenges of the aging epidemic.
The number and percentage of people throughout the world who will be 60 years of age and older are steadily growing due to reduced fertility rate and longer life expectancy. We are facing the prospect that large numbers of individuals in countries throughout the world will be living longer with disability and pain resulting from age-related disorders. We have a wide array of biomedical materials that could serve as the basis for treatments to deal with these problems. It is important to begin now to investigate how these biomaterials can be deployed in conjunction with the necessary biologics to treat lesions at an early stage of their development, while meeting the criteria of low cost and minimal invasiveness.